The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause / Chirgwin, J; Sun, Z; Smith, I; Price, Kn; Thürlimann, B; Ejlertsen, B; Bonnefoi, H; Regan, Mm; Goldhirsch, A; Coates, As; BIG 1-98 Collaborative and International Breast Cancer Study Group, (. . .; Mastropasqua, M; ., . . . ). - In: BREAST CANCER RESEARCH AND TREATMENT. - ISSN 0167-6806. - 131:(2012), pp. 295-306.